$15.50
+0 (+0%)
At Close: May 08, 2026
Medicago Begins Phase I Clinical Trials for its COVID-19 Vaccine Candidate
12:00am, Tuesday, 14'th Jul 2020
Medicago begins Phase I clinical trials for its COVID-19 vaccine candidate
First doses administered to human volunteers
Dynavax Technologies (DVAX) Dips More Than Broader Markets: What You Should Know
09:45pm, Monday, 13'th Jul 2020
In the latest trading session, Dynavax Technologies (DVAX) closed at $8.51, marking a -1.73% move from the previous day.
H.C. Wainwright Maintains Their Buy Rating on Dynavax (DVAX) - Markets
11:53am, Monday, 13'th Jul 2020
In a report released today, Edward White from H.C. Wainwright maintained a Buy rating on Dynavax (DVAX – Research Report),
TOKYO, Jul 13, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an industry-academia-government joint research agreement with four universities in Japan concerning the
Brokerages Anticipate Dynavax Technologies Co. (NASDAQ:DVAX) Will Announce Quarterly Sales of $5.71 Million
04:14am, Sunday, 12'th Jul 2020
Wall Street brokerages expect Dynavax Technologies Co. (NASDAQ:DVAX) to announce sales of $5.71 million for the current quarter, according to Zacks. Two analysts have made estimates for Dynavax Techno
- People with diabetes are two times more likely to become infected with the hepatitis B virus (HBV) and up to four times as likely to get HBV-related liver cancer - Hawaii.
If You Had Bought Dynavax Technologies (NASDAQ:DVAX) Shares A Year Ago You'd Have Earned133% Returns
02:09pm, Wednesday, 08'th Jul 2020
Unfortunately, investing is risky - companies can and do go bankrupt. But when you pick a company that is really...
Dynavax and Medicago Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
12:30pm, Wednesday, 08'th Jul 2020
EMERYVILLE, CA and QUEBEC CITY, CANADA / ACCESSWIRE / July 8, 2020 / Dynavax Technologies Corporation (DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, and
Do Options Traders Know Something About Dynavax Technologies (DVAX) Stock We Don't?
01:43pm, Tuesday, 07'th Jul 2020
Investors need to pay close attention to Dynavax Technologies (DVAX) stock based on the movements in the options market lately.
4 Solid Stocks to Buy on Renewed Hopes of Coronavirus Vaccine
12:23pm, Tuesday, 07'th Jul 2020
The past few months have seen pharmaceutical companies making every effort to develop a vaccine for the novel coronavirus.
Is Dynavax Technologies Stock a Buy? | The Motley Fool
01:16pm, Sunday, 05'th Jul 2020
This stock has the potential to break new highs with its key hepatitis B vaccine and emerging vaccine-adjuvant platform for COVID-19 vaccines.
Dynavax Technologies Co. (NASDAQ:DVAX) Shares Bought by Public Employees Retirement Association of Colorado
07:45am, Sunday, 05'th Jul 2020
Public Employees Retirement Association of Colorado lifted its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX) by 182.2% during the first quarter, according to its most recent filing with th
Coronavirus vaccine: Barrage of new data soon, Pfizer starts on positive note
06:52am, Thursday, 02'nd Jul 2020
Results from Pfizer and BioNTech kicked off the third quarter with a bang after a study in 45 healthy adults drove a high level of antibody responses in those getting two shots.A more detailed look at
Why COVID-19 Vaccine Developer Dynavax Is Down 6.5% Today | The Motley Fool
07:56pm, Wednesday, 01'st Jul 2020
Pfizer released intriguing data regarding its own COVID-19 vaccine.
Sign In
Buy DVAX